BSC
IBRX icon

BOLTON SECURITIES CORPORATION’s ImmunityBio IBRX Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.53K Buy
+1,030
New +$2.65K ﹤0.01% 1803
2025
Q1 		$3.1K Buy
+1,030
New +$3.12K ﹤0.01% 1663

Other funds holding IBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Heights Capital Management
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AlphaCore Capital
AlphaCore Capital La Jolla, California $6.24B AUM 19.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's IBRX Position: Q3 2025 in Review

BOLTON SECURITIES CORPORATION opened a new position in ImmunityBio (IBRX) in Q3 2025: 1,030 shares worth $2.53K. The stake represents ﹤0.01% of the portfolio and ranks #1803 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in IBRX as recently as Q1 2025.

BOLTON SECURITIES CORPORATION first reported a position in IBRX in Q1 2025 and has held it in 2 quarters since. The position peaked at $3.1K in Q1 2025. 264 funds tracked by Wall St. Rank hold IBRX as of Q3 2025.

  • BOLTON SECURITIES CORPORATION held 1,030 shares of ImmunityBio worth $2.53K as of Q3 2025.
  • ImmunityBio was a new BOLTON SECURITIES CORPORATION position in Q3 2025.
  • ImmunityBio made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2025, its #1803 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in ImmunityBio in Q1 2025 and has held it in 2 quarters since.
  • BOLTON SECURITIES CORPORATION's ImmunityBio position peaked at $3.1K in Q1 2025.
  • 264 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2025.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2025, filed 12 Nov 2026.